CD19-Targeted Chimeric Antigen Receptor T-cell Therapy for Concomitant Diffuse Large B-cell Lymphoma and Multiple Myeloma

Multiple myeloma (MM) and diffuse large B-cell lymphoma (DLBCL) comprise a large fraction of hematologic malignancies diagnosed each year. However, the co-occurrence of these conditions in the same patient is rare. CD19- and B-cell maturation antigen-targeted chimeric antigen receptor (CAR) T-cell t...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Ovidio, Tyler, Ciccolini, Kathryn, Kalac, Matko, Osman, Keren, Steinberg, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544703/
https://www.ncbi.nlm.nih.gov/pubmed/37790017
http://dx.doi.org/10.7759/cureus.44542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544703/
https://www.ncbi.nlm.nih.gov/pubmed/37790017
http://dx.doi.org/10.7759/cureus.44542

Ejemplares similares